BYND vs. BMY

Last updated Jun 13, 2026

BYND (Beyond Meat, Inc.) and BMY (Bristol-Myers Squibb Company) are both stocks. BYND operates in Packaged Foods (Consumer Defensive), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, BYND returned -65.98%/yr vs 0.73%/yr for BMY. At a 0.10 correlation, their price movements are largely independent.

Performance

BYND vs. BMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Beyond Meat, Inc. (BYND) and Bristol-Myers Squibb Company (BMY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BYND achieves a -16.91% return, which is significantly lower than BMY's 8.27% return.

BYND

• 1D: -3.20%
• 1M: -15.29%
• YTD: -16.91%
• 6M: -37.50%
• 1Y: -78.44%
• 3Y*: -63.44%
• 5Y*: -65.98%
• 10Y*: —

BMY

• 1D: 0.40%
• 1M: 0.23%
• YTD: 8.27%
• 6M: 11.43%
• 1Y: 20.57%
• 3Y*: 0.45%
• 5Y*: 0.73%
• 10Y*: 1.00%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BYND vs. BMY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
BYND Beyond Meat, Inc.	-16.91%	-78.19%	-57.75%	-27.70%	-81.11%	-47.87%	65.34%	64.35%
BMY Bristol-Myers Squibb Company	8.27%	0.11%	15.81%	-26.14%	18.98%	2.88%	0.41%	40.20%

Correlation

The correlation between BYND and BMY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.10
Correlation (All Time) Calculated using the full available price history since May 2, 2019	0.10

Fundamentals

Market Cap BYND : $325.51M BMY : $116.75B
EPS BYND : $1.03 BMY : $3.57
PE Ratio BYND : 0.66 BMY : 16.02
PS Ratio BYND : 0.52 BMY : 2.40
PB Ratio BYND : 4.35 BMY : 5.82
Total Revenue (TTM) BYND : $275.50M BMY : $48.48B
Gross Profit (TTM) BYND : $7.65M BMY : $33.33B
EBITDA (TTM) BYND : -$290.85M BMY : $13.34B

Return for Risk

BYND vs. BMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BYND

BYND Risk / Return Rank: 27
BYND Sharpe Ratio Rank: 28
BYND Sortino Ratio Rank: 42
BYND Omega Ratio Rank: 41
BYND Calmar Ratio Rank: 7
BYND Martin Ratio Rank: 16

BMY

BMY Risk / Return Rank: 65
BMY Sharpe Ratio Rank: 65
BMY Sortino Ratio Rank: 61
BMY Omega Ratio Rank: 58
BMY Calmar Ratio Rank: 71
BMY Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BYND vs. BMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Beyond Meat, Inc. (BYND) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BYND	BMY	Difference
Sharpe ratio: Return per unit of total volatility	-0.33	0.68	-1.02
Sortino ratio: Return per unit of downside risk	0.42	1.18	-0.76
Omega ratio: Gain probability vs. loss probability	1.05	1.14	-0.09
Calmar ratio: Return relative to maximum drawdown	-0.90	1.53	-2.43
Martin ratio: Return relative to average drawdown	-1.19	3.32	-4.51

BYND vs. BMY - Sharpe Ratio Comparison

The current BYND Sharpe Ratio is -0.33, which is lower than the BMY Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of BYND and BMY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BYND vs. BMY - Drawdown Comparison

The maximum BYND drawdown since its inception was -99.78%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for BYND and BMY.

Drawdown Indicators

	BYND	BMY	Difference
Max Drawdown Largest peak-to-trough decline	-99.78%	-72.03%	-27.75%
Max Drawdown (1Y) Largest decline over 1 year	-87.85%	-12.05%	-75.80%
Max Drawdown (3Y) Largest decline over 3 years	-97.06%	-36.85%	-60.21%
Max Drawdown (5Y) Largest decline over 5 years	-99.67%	-47.67%	-52.00%
Max Drawdown (10Y) Largest decline over 10 years	—	-47.67%	—
Current Drawdown Current decline from peak	-99.71%	-17.79%	-81.92%
Average Drawdown Average peak-to-trough decline	-75.62%	-22.38%	-53.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	66.55%	6.34%	+60.21%

Volatility

BYND vs. BMY - Volatility Comparison

Beyond Meat, Inc. (BYND) has a higher volatility of 20.19% compared to Bristol-Myers Squibb Company (BMY) at 8.22%. This indicates that BYND's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BYND	BMY	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.19%	8.22%	+11.97%
Volatility (6M) Calculated over the trailing 6-month period	75.70%	18.18%	+57.52%
Volatility (1Y) Calculated over the trailing 1-year period	236.92%	27.08%	+209.84%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	126.82%	24.02%	+102.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	117.26%	25.29%	+91.97%

Dividends

BYND vs. BMY - Dividend Comparison

BYND has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.38%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BMY Bristol-Myers Squibb Company	4.38%	4.60%	4.24%	4.44%	3.00%	2.36%	3.69%	2.55%	3.08%	2.55%	1.95%	2.17%
BYND Beyond Meat, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both BYND and BMY in my portfolio?

BYND and BMY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BYND or BMY?

BYND has higher volatility (20.19%) compared to BMY (8.22%). In terms of maximum drawdown, BYND dropped -99.78% vs BMY's -72.03%.

Which has better risk-adjusted returns?

BMY currently has the higher Sharpe Ratio (0.68 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.